Nature Medicine
3, 1176 (1997)
doi:10.1038/nm1197-1176b
Clear about cancer therapiesMichael J. Mckay1, 2
& Lester J. Peters1
1Division of Radiation Oncology, Peter Maccallum cancer Institute, St.Andrews place, Melbourne 3000, Australia
2Division of Radiation Research, Peter Maccallum cancer Institute, St.Andrews place, Melbourne 3000, Australia
REFERENCES
- Lamb, J. & Friend, S. Which guesstimate is the best guesstimate? Predicting chemotherapeutic outcomes. Nature Med. 3, 962−963 (1997) | Article | PubMed | ISI | ChemPort |
- Waldman, T. et al. Cell-cycle arrest versus cell death in cancer therapy. Nature Med. 3, 1034−1036 (1997). | Article | PubMed | ISI | ChemPort |
- McKay, M. & Langlands, A. The American "Patterns of Care" study: A model for the assessment of the quality of patient care in Radiation Oncology. Aust. Radiol. 34, 306−311 (1990). | ChemPort |
- Peters, L. The ESTRO Regaud Lecture: Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human normal tissue response. Radiother. Oncol. 17, 177−190 (1990). | PubMed | ISI | ChemPort |
|
